Next-Gen Proteins
Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This collection focuses on the entire protein innovation ecosystem. We've identified companies addressing the sustainable food challenge from multiple angles - creating plant-based alternatives, developing lab-grown meat, and improving traditional agriculture with better fertilizers and animal health solutions.
What You Need to Know
This investment opportunity spans both established agricultural players and emerging food-tech innovators. The theme aims to capture value across the entire protein production chain, from agricultural inputs to finished food products, positioning investors to benefit from long-term shifts in how we produce protein.
Why These Stocks
These companies were selected based on their technological innovation, market position, and growth potential in addressing global food challenges. Our experts identified businesses poised to benefit from increased consumer demand for sustainable protein sources and the regulatory support accelerating this industry.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+78.70%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 78.7% over the next year.
Stocks Rated Buy by Analysts
10 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.4% return last month.
Why You'll Want to Watch These Stocks
The Protein Revolution Is Here
Consumer demand for sustainable proteins is skyrocketing, with plant-based alternatives and cellular agriculture gaining mainstream acceptance faster than most analysts predicted.
Big Money Is Betting On Food Tech
Venture capital investment in alternative proteins hit record levels in recent years, with regulators increasingly supporting innovations that address food security and environmental concerns.
Breakthrough Technologies Emerging
From lab-grown meat to advanced agricultural systems, these companies are developing the technologies that could transform how we feed 10 billion people by 2050.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.